Clinical trial
Long-Term Follow-up Protocol for Subjects Treated With JCAR015
NCT02813252 is registered in ClinicalTrials.gov with Juno Therapeutics, a Subsidiary of Celgene as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Follow-up Protocol for Subjects Treated With JCAR015
- Lead sponsor
- Juno Therapeutics, a Subsidiary of Celgene
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 30, 2016
- Completion date
- October 22, 2021
- Enrollment
- 15 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia